Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ursolic Acid Derivative. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102260315A details a novel ethylenediamine-linked ursolic acid derivative synthesis. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel synthesis route for high-purity ursolic acid derivatives offering cost reduction and scalable supply chain solutions for pharmaceutical manufacturing.
Patent CN105693815A details a novel synthesis route for high-purity piperazine-modified ursolic acid derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN102532245B details a cost-effective synthesis of ursolic acid derivatives for leukemia treatment, offering significant advantages in API manufacturing efficiency.
Patent CN107602658A reveals a novel synthesis for high-purity ursolic acid derivatives with significant antitumor activity and simplified commercial manufacturing processes.
Patent CN103626828A details novel ursolic acid modifications enhancing antitumor activity. This report analyzes scalable synthesis routes for reliable pharmaceutical intermediate supply chains.
Explore the advanced synthesis of ursolic acid chalcone and pyrazoline esters via patent CN101830961B. Discover cost-effective routes for high-purity oncology intermediates.
Patent CN102516351A details novel ursolic acid derivatives with enhanced anti-cancer activity and reduced toxicity, offering cost reduction in API manufacturing.
Advanced synthesis of ursolic acid benzimidazole esters via patent CN102250188B. Offers cost reduction in pharmaceutical intermediate manufacturing and scalable routes.
Patent CN101830961A details novel ursolic acid esters with enhanced antitumor activity via efficient Claisen-Schmidt condensation and esterification routes suitable for scale-up.